Bone morphogenetic protein-4: a novel therapeutic target for pathological cardiac hypertrophy/heart failure.
about
Targeting BMP signalling in cardiovascular disease and anaemiaOestrogen inhibits BMP4-induced BMP4 expression in cardiomyocytes: a potential mechanism of oestrogen-mediated protection against cardiac hypertrophy.GDF11/BMP11 activates both smad1/5/8 and smad2/3 signals but shows no significant effect on proliferation and migration of human umbilical vein endothelial cells.Endothelial dysfunction and vascular disease - a 30th anniversary update.Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity.Meox1 accelerates myocardial hypertrophic decompensation through Gata4.
P2860
Bone morphogenetic protein-4: a novel therapeutic target for pathological cardiac hypertrophy/heart failure.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Bone morphogenetic protein-4: ...... iac hypertrophy/heart failure.
@en
type
label
Bone morphogenetic protein-4: ...... iac hypertrophy/heart failure.
@en
prefLabel
Bone morphogenetic protein-4: ...... iac hypertrophy/heart failure.
@en
P2860
P1476
Bone morphogenetic protein-4: ...... iac hypertrophy/heart failure.
@en
P2093
De-Li Dong
Wen-Ting Guo
P2860
P2888
P304
P356
10.1007/S10741-014-9429-8
P577
2014-11-01T00:00:00Z